Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page
- Check5 days agoChange DetectedRecruitment status on the study page now indicates enrollment is closed. The page also adds new help and navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision label to v3.6.0, with a minor formatting change to the Intervention/Treatment header.SummaryDifference0.3%

- Check12 days agoChange DetectedThe page's revision stamp was updated from v3.5.4 to v3.5.5, indicating a version upgrade.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision tag was updated to v3.5.4, replacing the previous v3.5.3. This denotes a minor page update without altering the study content or public details.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated to v3.5.2 (replacing v3.5.0).SummaryDifference0.0%

- Check91 days agoChange DetectedStatus updated from Active, not recruiting to Completed with completion date 2026-02-12, and page revision updated to Revision: v3.5.0.SummaryDifference0.3%

Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.